1126 related articles for article (PubMed ID: 30738402)
21. Whole brain radiation therapy (WBRT) alone versus WBRT and radiosurgery for the treatment of brain metastases.
Patil CG; Pricola K; Sarmiento JM; Garg SK; Bryant A; Black KL
Cochrane Database Syst Rev; 2017 Sep; 9(9):CD006121. PubMed ID: 28945270
[TBL] [Abstract][Full Text] [Related]
22. Concurrent Lapatinib With Brain Radiation Therapy in Patients With HER2+ Breast Cancer With Brain Metastases: NRG Oncology-KROG/RTOG 1119 Phase 2 Randomized Trial.
Kim IA; Winter KA; Sperduto PW; De Los Santos JF; Peereboom DM; Ogunleye T; Boulter D; Fritz JM; Cho KH; Shin KH; Zoberi I; Choi S; Palmer JD; Liem B; Kim YB; Anderson BM; Thakrar AW; Muanza TM; Kim MM; Choi DH; Mehta MP; White JR
Int J Radiat Oncol Biol Phys; 2024 Apr; 118(5):1391-1401. PubMed ID: 37506981
[TBL] [Abstract][Full Text] [Related]
23. Cost-effectiveness of stereotactic radiosurgery with and without whole-brain radiotherapy for the treatment of newly diagnosed brain metastases.
Hall MD; McGee JL; McGee MC; Hall KA; Neils DM; Klopfenstein JD; Elwood PW
J Neurosurg; 2014 Dec; 121 Suppl():84-90. PubMed ID: 25434941
[TBL] [Abstract][Full Text] [Related]
24. Concurrent Immune Checkpoint Inhibitors and Stereotactic Radiosurgery for Brain Metastases in Non-Small Cell Lung Cancer, Melanoma, and Renal Cell Carcinoma.
Chen L; Douglass J; Kleinberg L; Ye X; Marciscano AE; Forde PM; Brahmer J; Lipson E; Sharfman W; Hammers H; Naidoo J; Bettegowda C; Lim M; Redmond KJ
Int J Radiat Oncol Biol Phys; 2018 Mar; 100(4):916-925. PubMed ID: 29485071
[TBL] [Abstract][Full Text] [Related]
25. A systematic review of trastuzumab and lapatinib in the treatment of women with brain metastases from HER2-positive breast cancer.
Larsen PB; Kümler I; Nielsen DL
Cancer Treat Rev; 2013 Nov; 39(7):720-7. PubMed ID: 23481218
[TBL] [Abstract][Full Text] [Related]
26. Management of Brain Metastases in Tyrosine Kinase Inhibitor-Naïve Epidermal Growth Factor Receptor-Mutant Non-Small-Cell Lung Cancer: A Retrospective Multi-Institutional Analysis.
Magnuson WJ; Lester-Coll NH; Wu AJ; Yang TJ; Lockney NA; Gerber NK; Beal K; Amini A; Patil T; Kavanagh BD; Camidge DR; Braunstein SE; Boreta LC; Balasubramanian SK; Ahluwalia MS; Rana NG; Attia A; Gettinger SN; Contessa JN; Yu JB; Chiang VL
J Clin Oncol; 2017 Apr; 35(10):1070-1077. PubMed ID: 28113019
[TBL] [Abstract][Full Text] [Related]
27. Salvage stereotactic radiosurgery for breast cancer brain metastases: outcomes and prognostic factors.
Kelly PJ; Lin NU; Claus EB; Quant EC; Weiss SE; Alexander BM
Cancer; 2012 Apr; 118(8):2014-20. PubMed ID: 21918959
[TBL] [Abstract][Full Text] [Related]
28. Role of HER2 status in the treatment for brain metastases arising from breast cancer with stereotactic radiosurgery.
Tam M; Narayana A; Raza S; Kunnakkat S; Golfinos JG; Parker EC; Novik Y
Med Oncol; 2014 Feb; 31(2):832. PubMed ID: 24390418
[TBL] [Abstract][Full Text] [Related]
29. Current Treatment Options for Breast Cancer Brain Metastases.
Raghunath A; Desai K; Ahluwalia MS
Curr Treat Options Oncol; 2019 Feb; 20(3):19. PubMed ID: 30771009
[TBL] [Abstract][Full Text] [Related]
30. Adverse Radiation Effect and Disease Control in Patients Undergoing Stereotactic Radiosurgery and Immune Checkpoint Inhibitor Therapy for Brain Metastases.
Koenig JL; Shi S; Sborov K; Gensheimer MF; Li G; Nagpal S; Chang SD; Gibbs IC; Soltys SG; Pollom EL
World Neurosurg; 2019 Jun; 126():e1399-e1411. PubMed ID: 30902777
[TBL] [Abstract][Full Text] [Related]
31. Comparison of Local Control of Brain Metastases With Stereotactic Radiosurgery vs Surgical Resection: A Secondary Analysis of a Randomized Clinical Trial.
Churilla TM; Chowdhury IH; Handorf E; Collette L; Collette S; Dong Y; Alexander BM; Kocher M; Soffietti R; Claus EB; Weiss SE
JAMA Oncol; 2019 Feb; 5(2):243-247. PubMed ID: 30419088
[TBL] [Abstract][Full Text] [Related]
32. CDK 4/6 inhibitors and stereotactic radiation in the management of hormone receptor positive breast cancer brain metastases.
Figura NB; Potluri TK; Mohammadi H; Oliver DE; Arrington JA; Robinson TJ; Etame AB; Tran ND; Liu JK; Soliman H; Forsyth PA; Sahebjam S; Yu HM; Han HS; Ahmed KA
J Neurooncol; 2019 Sep; 144(3):583-589. PubMed ID: 31399935
[TBL] [Abstract][Full Text] [Related]
33. Stereotactic radiosurgery as primary and salvage treatment for brain metastases from breast cancer. Clinical article.
Kondziolka D; Kano H; Harrison GL; Yang HC; Liew DN; Niranjan A; Brufsky AM; Flickinger JC; Lunsford LD
J Neurosurg; 2011 Mar; 114(3):792-800. PubMed ID: 20887087
[TBL] [Abstract][Full Text] [Related]
34. A phase 3 trial of whole brain radiation therapy and stereotactic radiosurgery alone versus WBRT and SRS with temozolomide or erlotinib for non-small cell lung cancer and 1 to 3 brain metastases: Radiation Therapy Oncology Group 0320.
Sperduto PW; Wang M; Robins HI; Schell MC; Werner-Wasik M; Komaki R; Souhami L; Buyyounouski MK; Khuntia D; Demas W; Shah SA; Nedzi LA; Perry G; Suh JH; Mehta MP
Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):1312-8. PubMed ID: 23391814
[TBL] [Abstract][Full Text] [Related]
35. The impact of whole-brain radiation therapy on the long-term control and morbidity of patients surviving more than one year after gamma knife radiosurgery for brain metastases.
Varlotto JM; Flickinger JC; Niranjan A; Bhatnagar A; Kondziolka D; Lunsford LD
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1125-32. PubMed ID: 15990018
[TBL] [Abstract][Full Text] [Related]
36. Multiinstitutional prospective observational study of stereotactic radiosurgery for patients with multiple brain metastases from non-small cell lung cancer (JLGK0901 study-NSCLC).
Shuto T; Akabane A; Yamamoto M; Serizawa T; Higuchi Y; Sato Y; Kawagishi J; Yamanaka K; Jokura H; Yomo S; Nagano O; Aoyama H
J Neurosurg; 2018 Dec; 129(Suppl1):86-94. PubMed ID: 30544291
[TBL] [Abstract][Full Text] [Related]
37. Whole brain radiation therapy (WBRT) alone versus WBRT and radiosurgery for the treatment of brain metastases.
Patil CG; Pricola K; Garg SK; Bryant A; Black KL
Cochrane Database Syst Rev; 2010 Jun; (6):CD006121. PubMed ID: 20556764
[TBL] [Abstract][Full Text] [Related]
38. Effects of systemic therapy and local therapy on outcomes of 873 breast cancer patients with metastatic breast cancer to brain: MD Anderson Cancer Center experience.
Gao C; Wang F; Suki D; Strom E; Li J; Sawaya R; Hsu L; Raghavendra A; Tripathy D; Ibrahim NK
Int J Cancer; 2021 Feb; 148(4):961-970. PubMed ID: 32748402
[TBL] [Abstract][Full Text] [Related]
39. Treatment of cerebral metastases from breast cancer with stereotactic radiosurgery.
Combs SE; Schulz-Ertner D; Thilmann C; Edler L; Debus J
Strahlenther Onkol; 2004 Sep; 180(9):590-6. PubMed ID: 15378190
[TBL] [Abstract][Full Text] [Related]
40. Risk of leptomeningeal disease in patients treated with stereotactic radiosurgery targeting the postoperative resection cavity for brain metastases.
Atalar B; Modlin LA; Choi CY; Adler JR; Gibbs IC; Chang SD; Harsh GR; Li G; Nagpal S; Hanlon A; Soltys SG
Int J Radiat Oncol Biol Phys; 2013 Nov; 87(4):713-8. PubMed ID: 24054875
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
